James Buchanan

James Buchanan

University of Oxford

H-index: 21

Europe-United Kingdom

About James Buchanan

James Buchanan, With an exceptional h-index of 21 and a recent h-index of 19 (since 2020), a distinguished researcher at University of Oxford, specializes in the field of Health Economics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Paving the path for implementation of clinical genomic sequencing globally-Are we ready?

Secondary (additional) findings from the 100,000 Genomes Project: Disease manifestation, health care outcomes, and costs of disclosure

Evaluating the Impact of Genome Sequencing on Healthcare Resource Use: Evidence from Cancer Patients

Using “big data” for economic evaluations in genomics

QALYs and Rare Diseases: exploring the responsiveness of SF-6D, EQ-5D-5L and AQoL-8D following genomic testing for childhood and adult-onset rare genetic conditions in Australia

Economic Evaluation in Genomic and Precision Medicine

Retrospective file review shows limited genetic services fail most patients–an argument for the implementation of exome sequencing as a first-tier test in resource-constrained …

Factors that impact on women's decision‐making around prenatal genomic tests: An international discrete choice survey

James Buchanan Information

University

Position

Senior Researcher

Citations(all)

2391

Citations(since 2020)

2056

Cited By

926

hIndex(all)

21

hIndex(since 2020)

19

i10Index(all)

34

i10Index(since 2020)

32

Email

University Profile Page

University of Oxford

Google Scholar

View Google Scholar Profile

James Buchanan Skills & Research Interests

Health Economics

Top articles of James Buchanan

Title

Journal

Author(s)

Publication Date

Paving the path for implementation of clinical genomic sequencing globally-Are we ready?

Health Affairs Scholar

Deborah A Marshall

Nicolle Hua

James Buchanan

Kurt D Christensen

Geert WJ Frederix

...

2024/4/29

Secondary (additional) findings from the 100,000 Genomes Project: Disease manifestation, health care outcomes, and costs of disclosure

Genetics in Medicine

Joshua Nolan

James Buchanan

John Taylor

Joao Almeida

Tina Bedenham

...

2024/3/1

Evaluating the Impact of Genome Sequencing on Healthcare Resource Use: Evidence from Cancer Patients

Academy of Management Proceedings

Sandra Barbosu

Sarah Wordsworth

John Buckell

James Buchanan

2023

Using “big data” for economic evaluations in genomics

Sarah Wordsworth

Brett Doble

Katherine Payne

James Buchanan

Deborah Marshall

...

2023/1/1

QALYs and Rare Diseases: exploring the responsiveness of SF-6D, EQ-5D-5L and AQoL-8D following genomic testing for childhood and adult-onset rare genetic conditions in Australia

Health and Quality of Life Outcomes

T Pan

Y Wu

J Buchanan

I Goranitis

2023/12/2

Economic Evaluation in Genomic and Precision Medicine

Christina Mitropoulou

Sarah Wordsworth

James Buchanan

George P Patrinos

2023/4/19

Retrospective file review shows limited genetic services fail most patients–an argument for the implementation of exome sequencing as a first-tier test in resource-constrained …

Orphanet Journal of Rare Diseases

Emma K Wiener

James Buchanan

Amanda Krause

Zané Lombard

DDD-Africa Study

...

2023/4/12

Factors that impact on women's decision‐making around prenatal genomic tests: An international discrete choice survey

James Buchanan

Melissa Hill

Caroline M Vass

Jennifer Hammond

Sam Riedijk

...

2022/6

Eliciting risk preferences that predict risky health behavior: A comparison of two approaches

Health economics

Murong Yang

Laurence SJ Roope

James Buchanan

Arthur E Attema

Philip M Clarke

...

2022/5

Resource allocation in genetic and genomic medicine

Journal of Community Genetics

J Buchanan

I Goranitis

I Slade

A Kerasidou

M Sheehan

...

2022/10

Women's preferences for receiving uncertain results from prenatal genomic testing: An international discrete choice experiment

Celine Lewis

James Buchanan

Jennifer Hammond

Sam Riedijk

Jasmijn Klapwijk

...

2022/4/1

Defining a Core Data Set for the Economic Evaluation of Precision Oncology

Samantha Pollard

Deirdre Weymann

Brandon Chan

Morgan Ehman

Sarah Wordsworth

...

2022/8/1

Assessing women’s preferences towards tests that may reveal uncertain results from prenatal genomic testing: Development of attributes for a discrete choice experiment, using a …

Jennifer Hammond

Jasmijn E Klapwijk

Sam Riedijk

Stina Lou

Kelly E Ormond

...

2022/1/28

Financing and reimbursement models for personalised medicine: A systematic review to identify current models and future options

Rositsa Koleva-Kolarova

James Buchanan

Heleen Vellekoop

Simone Huygens

Matthijs Versteegh

...

2022/7

100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care—Preliminary Report

New England Journal of Medicine

100

000 Genomes Project Pilot Investigators

2021/11/11

Availability and funding of clinical genomic sequencing globally

Kathryn A Phillips

Michael P Douglas

Sarah Wordsworth

James Buchanan

Deborah A Marshall

2021/2/1

Mixed-methods evaluation of the NHS Genomic Medicine Service for paediatric rare diseases: study protocol

NIHR open research

Celine Lewis

James Buchanan

Angus Clarke

Emma Clement

Bettina Friedrich

...

2021

Toward the diagnosis of rare childhood genetic diseases: what do parents value most?

European Journal of Human Genetics

Samantha Pollard

Deirdre Weymann

Jessica Dunne

Fatemeh Mayanloo

John Buckell

...

2021/10

Public preferences for delayed or immediate antibiotic prescriptions in UK primary care: A choice experiment

PLoS medicine

Liz Morrell

James Buchanan

Laurence SJ Roope

Koen B Pouwels

Christopher C Butler

...

2021/8/30

Cost-Effectiveness of Amphotericin B Deoxycholate Versus Itraconazole for Induction Therapy of Talaromycosis in Human Immunodeficiency Virus–Infected Adults in Vietnam

Open Forum Infectious Diseases

James Buchanan

James Altunkaya

Nguyen Van Kinh

Nguyen Van Vinh Chau

Vo Trieu Ly

...

2021/7

See List of Professors in James Buchanan University(University of Oxford)

Co-Authors

H-index: 103
Sarah Walker

Sarah Walker

University of Oxford

H-index: 58
Kathryn A. Phillips

Kathryn A. Phillips

University of California, San Francisco

H-index: 55
Anna Schuh

Anna Schuh

University of Oxford

H-index: 44
Sarah Wordsworth, PhD

Sarah Wordsworth, PhD

University of Oxford

H-index: 42
Koen B Pouwels

Koen B Pouwels

University of Oxford

H-index: 33
Sarah Tonkin-Crine

Sarah Tonkin-Crine

University of Oxford

academic-engine